Bio-Techne Corporation TECH NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

64/100

3/7 Pass

SharesGrow Intrinsic Value

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Bio-Techne Corporation (TECH) reported total assets of $2.56B and total liabilities of $639.06M for fiscal year 2025, resulting in total equity of $1.92B.

The company held $162.19M in cash and short-term investments. Total debt stood at $444.06M, with net debt of $281.87M. The Debt-to-Equity (D/E) ratio was 0.23 (conservative).

Current ratio is 3.46, indicating strong short-term liquidity. Interest coverage is 12x (strong).

Criteria supported by this page:

HEALTH (100/100, Pass) — Debt-to-Equity of 0.23, current ratio of 3.46, interest coverage 12x — balance sheet is strong
MOAT (65/100) — Total assets $2.56B and equity $1.92B support the company's competitive scale
VALUE (27/100) — Debt-to-Equity 0.23 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 64/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score

64/100

SG Score

View full scorecard →

✗

VALUE

27/100

Price-to-Earnings & upside

→ Valuation

✓

FUTURE

79/100

Analyst consensus

→ Forecast

✓

PAST

100/100

→ Income

✓

HEALTH

100/100

Debt-to-Equity & liquidity

Proven by this page

MOAT

65/100

→ Income

✗

GROWTH

30/100

→ Income

INCOME

45/100

→ Income

Bio-Techne Corporation Balance Sheet History

Metric	FY2025	FY2024	FY2023	FY2022
Total Assets	$2.56B	$2.7B	$2.64B	$2.29B
Total Liabilities	$639.06M	$635.02M	$672.18M	$593.79M
Total Debt	$444.06M	$419.54M	$454.97M	$325.97M
Cash & Investments	$162.19M	$152.86M	$204.31M	$247.03M
Total Stockholders Equity	$1.92B	$2.07B	$1.97B	$1.7B